Full-Time

Territory Manager

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$86k - $96k/yr

+ Incentive

Mid, Senior

Indianapolis, IN, USA

Minimum of 4 days of in-office presence required per week.

Category
Field Sales
Sales & Account Management
Requirements
  • Product knowledge and all features and benefits of BDPI products Surgical procedure knowledge, adequate to illustrate our product benefits.
  • Basic anatomy.
  • Medical and surgical terminology.
  • Through understanding of needs/analysis selling.
  • Excellent listening and communication skills.
  • Understands contract administration
Responsibilities
  • Sells the entire product line to current and new accounts.
  • Informs customers of new and current pricing, backorders, and company policies.
  • Executes comprehensive in-service of products to all concerned individuals.
  • Plans sales calls on a continuous basis, managing sales time effectively.
  • Develops thorough knowledge of all products and clinical data.
  • Informs Regional Manager of significant market changes and competitive activity.
  • Achieves prompt, mutually satisfactory solutions to customer complaints.
  • Analyzes customer needs and creates solutions.
  • Maintains company automobile and company property.
  • Completes and processes BDPI reports including but not limited to: sales summary reports, expense reports, monthly product tracking reports, account targeting reports, and complaint reports in accordance with established policies and procedures.
Desired Qualifications
  • Medical Device Sales experience preferred but not required.

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products. Its products are used by hospitals, laboratories, and healthcare providers worldwide to enhance patient care and improve health outcomes. BD operates in several segments, including BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. What sets BD apart from its competitors is its comprehensive approach to healthcare, offering a wide range of solutions that not only improve patient outcomes but also help reduce costs and increase efficiency in healthcare delivery. The company's goal is to advance healthcare by providing innovative solutions that expand access to medical services and improve safety for patients and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth boosts BD's remote patient monitoring devices.
  • Personalized medicine growth increases need for BD's advanced diagnostic tools.
  • Wearable medical devices market expansion offers BD new technology opportunities.

What critics are saying

  • Increased competition from emerging markets may impact BD's market share.
  • Rapid technological advancements require continuous R&D investment from BD.
  • Global talent shortage could affect BD's innovation and operational efficiency.

What makes Becton Dickinson unique

  • BD's $1.2B investment enhances syringe and drug delivery manufacturing capabilities.
  • Acquisition of Cubex LLC's assets boosts BD's cloud-based medical software offerings.
  • BD's global presence spans North America, EMEA, Greater Asia, and Latin America.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...